BRD4 and nevus comedonicus syndrome: Recently, two concurrently published NC genetically engineered mouse models (GEMMs) have demonstrated that BRD4::NUTM1 is sufficient as a sole oncogenic driver to initiate aggressive tumors resembling human NC (hNC) (13, 14).